Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market se

Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's a

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

The agreement establishes BioHorizons as the exclusive distributor of Xtant's allogeneic growth

Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic

Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regul

Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript

Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the anal

Xtant Medical Hldgs (AMEX:XTNT) lowers FY2026 sales outlook from $101.000 million-$105.000 million t

Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized

BELGRADE, Mont., Aug. 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a

BELGRADE, Mont., Aug. 4, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a

Xtant Medical NYSEAMERICAN: XTNT raised its full-year 2026 revenue guidance after announcing a distr

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintain

2026 Financial GuidanceThe Company is today increasing its full-year 2026 revenue guidance to a rang

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst

Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens bal

BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a m

BELGRADE, Mont., May 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a m

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical

Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST ® Bellows product and pen

BELGRADE, Mont., April 9, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), i

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the p

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Hldgs (AMEX:XTNT) sees FY2026 sales of $95.000 million-$99.000 million vs $110.100 mil

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly sales of $32.357 million which beat the analyst c

Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers posit

BELGRADE, Mont., March 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT),

Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Compani

Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Compani

BELGRADE, Mont., Feb. 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a

AWM Investment Company Inc. purchased a new stake in shares of Xtant Medical Holdings, Inc. (NYSEAME

nanOss Strata™ is designed to more closely mimic the structure of human bone, increase the graft's s

BELGRADE, Mont. , Dec. 1, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a

BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the p

Xtant Medical Hldgs (AMEX:XTNT) affirms FY2025 sales outlook from $131.000 million-$135.000 million

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.01 per share which beat the analys

Xtant Medical Hldgs (AMEX:XTNT) raises FY2025 sales outlook from $127.000 million-$131.000 million t

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.02 per share which beat the analys